Core Viewpoint - The "Management Measures for Open Sharing of Major Scientific Research Infrastructure and Large Scientific Instruments in Sichuan Province" aims to enhance the efficiency of scientific resource utilization and promote technological innovation and achievement transformation through open sharing of research facilities and instruments [1][2]. Group 1: Definition and Scope - Major scientific research infrastructure and large scientific instruments refer to facilities and equipment valued at 500,000 yuan or more, funded by public finance or state-owned capital, which are used for scientific research and technological development [2]. - The management units are responsible for the open sharing of these facilities and instruments, including the establishment of relevant systems and the operation of the sharing platform [2]. Group 2: Platform and Service Requirements - Management units are required to integrate their research facilities into the Sichuan Provincial Large Instrument Sharing Platform, ensuring standardized management and transparency in service offerings [3]. - Open sharing services can charge fees based on cost recovery and non-profit principles, with revenue contributing to performance-based salary funding for technical and administrative staff [3]. Group 3: Performance Evaluation and Accountability - An annual assessment will be conducted, rewarding "excellent" management units with preferential treatment in project applications and penalties for "unsatisfactory" units, including public notification and mandated corrections [4]. - Failure to comply with sharing obligations may result in corrective actions and penalties for responsible personnel [4].

综观2024年度山东省科学技术奖的获奖成果，学科前沿交叉和应用导向性进一步凸显。在51项自然 科学奖成果中，有21项呈现出明显的学科交叉性，如新型二维材料与光电子学交叉、微技术和物理学交 叉、生物学和智能计算技术交叉等。基础研究和应用研究的相互促进、相互结合越来越紧密，不仅提升 了科技竞争中的话语权，更为产业升级提供了源头活水。 重贡献重实效，山东科技成果评价之变 学科前沿交叉和应用导向性进一步凸显 科技创新与产业创新深度融合成突出特点 6月27日，全省科技大会在济南召开，会上宣读了2024年度山东省科学技术奖励决定。山东大学刘 建亚、山东第一医科大学张福仁荣膺山东省科学技术奖最高奖，51个项目获自然科学奖、32个项目获技 术发明奖、190个项目获科学技术进步奖，山东大学张百涛等10人获科学技术青年奖，另有5人获国际科 学技术合作奖。 山东作为全国科技奖励改革唯一试点省，通过科学技术奖提名机制优化，重点倾斜从0到1的重大科 学发现和基础理论创新，在关键核心技术领域取得重大突破、抢占科技和产业发展制高点的战略性、前 沿性成果，推动科技成果评价从"唯论文、唯职称"向"重贡献、重实效"转型。这一导向在本次获奖项目 ...

证券研究报告 关税影响显现，5 月工企利润同比转负 华泰研究 2025 年 6 月 27 日│中国内地 动态点评 5 月工业企业利润数据点评 今年 5 月工业企业盈利同比增速较 4 月的 3%明显回落至-9.1%，出口相关 的中游制造业量价有所承压、或显示关税政策对企业利润率及订单的影响 显现，下游部分消费品行业或受促销影响、呈现"量增价跌"，亦对盈利形 成扰动。整体而言，工业企业收入同比增速从 4 月的 2.6%继续回落至 0.8%， 与 5 月出口增速放缓相印证，出口链相关行业盈利回升态势受阻，关税影响 或逐步凸显，电气机械、仪器仪表、专用设备、计算机通信等行业利润率及 收入增速均有回落；同时，油价及黑色系价格下跌对石化及煤炭开采等行业 利润率回升持续形成压制，对应中下游的石化加工相关行业盈利边际改善； 此外，汽车、服装、文教娱乐用品等行业营收增速回升，但盈利增速走弱， 或显示出购物节促销等因素对价格的拖累。 往前看，7 月 9 日"对等关税"豁免期后关税政策仍有较大扰动，外需不确 定性或对后续出口订单带来扰动，尤其是对企业利润率的影响或逐步显现。 内需层面，"以旧换新"政策补贴使用过半，虽然三四季度补贴 ...

证券代码：300515 证券简称：三德科技 湖南三德科技股份有限公司投资者关系活动记录表 编号：2025-007 | | 特定对象调研□分析师会议 | | --- | --- | | 投资者关系活动 | □媒体采访□业绩说明会 | | | □新闻发布会□路演活动 | | 类别 | 现场参观 | | | □其他 | | | 东方财富证券周喆；国投瑞银基金贺明之、李研蓉、朴虹睿、 冯新月；汇添富基金郑磊； | | 参与单位名称及 | 国泰君安证券于歆；友邦人寿丁戈； | | 人员姓名 | 东方财富证券周旭辉；创富启航张人亮；喻德安；谢红；刘 | | | 焕煊。 | | | （以上排名不分先后） | | 时间 | 2025 年 6 月 24 日、6 月 27 日 | | 地点 | 公司会议室、产品体验中心 | | 上市公司接待 | 副总经理兼董事会秘书唐芳东 | | 人员姓名 | 证券事务代表邓意欣 | | | 一、公司基本情况 公司创立于 1993 年，现有分析仪器、无人化智能装备两个产 | | | 品群以及衍生于前述两个产品群的运维等技术服务三个业务板块。 | | 投资者关系活动 | 公司产品主要用于煤炭质 ...

耗材 渠道销售经理 北京- 18k-28k ·13薪 特别提示 微信公众号机制调整，请点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 仪粉e r们，今天是高薪精品仪器职位专辑，有不少 新的雇主 哦！ 销售精英，热招职位 Ho t r e c r u itme n t p o siti o n s 安捷伦科技（中国）有限公司 任职要求： 3~5年渠道管理经验，具有仪器耗材或相关领域背景优先；丰富的实验室行业销售经验者优先。 扫描二维码 投递你的简历 欧世盛（北京）科技有限公司 大客户销售经理 北京-20k-30k ·20薪 任职要求： 具有本科及以上学历，专业不限；具有To B端大项目销售经验，具备做大客户关系的能力，一定的市场分析及判断能力。 上海科哲生化科技有限公司 自动化项目销售经理 上海-13k-22k ·12薪 任职要求： 要求本科以上学历，相关行业3年以上工作经验。 屹尧科技 质谱产品销售经理 杭州-15k-25k ·12薪 任职要求： 5年以上仪器行业相关工作经验，具备AA\ ICP-OES& ICP-MS等无机产品及相关耗材的销售经验，有无机四极杆质 ...

Group 1: Company Announcements - Jingce Electronics' subsidiary signed sales contracts for semiconductor measurement equipment totaling 113 million yuan [1] - Zhifei Biological plans to issue company bonds not exceeding 6 billion yuan for technology innovation and working capital [1] - Rijiu Optoelectronics' subsidiary plans to invest 822 million yuan in a functional film project with an annual production capacity of 6 million square meters [1] - Huiyun Titanium Industry's subsidiary intends to acquire a 53.125% stake in Chenshang Mining for 30.6 million yuan and increase capital by 32.4 million yuan [2] - Hongte Technology plans to raise up to 650 million yuan through a rights issue for various projects and working capital [2] - Jincheng Pharmaceutical's subsidiary received FDA approval for the active pharmaceutical ingredient Posaconazole [4] - Kairun Co. plans to reduce its shareholding by up to 2% due to personal funding needs [5] - Rundou Co. passed an FDA inspection for nine active pharmaceutical ingredients [6] - Sanyou Lianzhong's shareholders plan to reduce their holdings by up to 3% due to funding needs [7] - *ST Yazhen's stock was suspended for trading due to a significant price increase of 29.43% [9] - Online and Offline plans to change control with a share transfer agreement, leading to a new controlling shareholder [10] - Dazhong Mining intends to purchase office space from an affiliate for 50.17 million yuan [11] - Suzhou Bank's major shareholder increased its stake by 856 million yuan [12] - *ST Fanli's subsidiary plans to acquire a 60% stake in Guangzhou Fengteng for up to 28.8 million yuan [14] - Hengmingda's major shareholders plan to reduce their holdings by up to 3.15% [16] - Guomai Technology's shareholder plans to reduce its stake by up to 1% due to funding needs [17] - ST Bailin's stock will change its name to Guizhou Bailin and remove risk warnings [17] - *ST Xianfeng's stock will change its name to Xianfeng Holdings and remove risk warnings [18] - Maiwei Bio signed an exclusive licensing agreement with CALICO for a monoclonal antibody, receiving an upfront payment of 25 million USD [19] - Maiwei Bio signed a technology licensing agreement with Qilu Pharmaceutical for a new drug project, with a total payment of up to 500 million yuan [21] - Maiwei Bio plans to repurchase shares worth between 25 million and 50 million yuan [22] - Mengwang Technology plans to acquire 100% of Bicheng Digital for 1.28 billion yuan to expand its e-commerce services [22] Group 2: Industry Overview - Jingce Electronics operates in the mechanical equipment sector, focusing on measurement systems for displays, semiconductors, and new energy [1] - Zhifei Biological is in the pharmaceutical sector, specializing in vaccine and biological product development [1] - Rijiu Optoelectronics is part of the electronics industry, focusing on touch display materials and functional films [1][2] - Huiyun Titanium Industry operates in the basic chemicals sector, focusing on titanium dioxide products [2] - Hongte Technology is in the automotive industry, specializing in aluminum alloy precision die-casting for automotive components [2][3] - Jincheng Pharmaceutical is in the pharmaceutical sector, focusing on chemical pharmaceuticals and active ingredients [4] - Rundou Co. operates in the pharmaceutical sector, focusing on chemical drug formulations and raw materials [6] - Sanyou Lianzhong is in the electrical equipment sector, specializing in relays and transformers [7] - *ST Yazhen operates in the light industry, focusing on high-end furniture products [9] - Online and Offline is in the communication sector, focusing on communication services and applications [10] - Dazhong Mining operates in the steel industry, focusing on iron ore mining and processing [11] - Suzhou Bank is a city commercial bank, providing various banking services [12] - *ST Fanli operates in the media sector, focusing on online advertising and marketing services [14] - Hengmingda is in the electronics sector, focusing on precision components for consumer electronics [16] - Guomai Technology operates in the education sector, focusing on IoT technology services [17] - ST Bailin is in the energy sector, providing engineering consulting and smart factory solutions [17] - *ST Xianfeng operates in the animal health sector, focusing on vaccines and animal nutrition [18] - Maiwei Bio is in the pharmaceutical sector, focusing on biopharmaceuticals [19][21][22] - Mengwang Technology operates in the communication sector, focusing on cloud platform services [22]

温州加快提升高能级科创平台建设质效显现，温州市3家省级新型研发机构成为牵头建设全省重点实验室的依托单位。 国科温州研究院牵头建设全省软物质生物医学材料重点实验室，华中科技大学温州先进制造技术研究院牵头建设全省电 子功能陶瓷材料与器件重点实验室，温州大学碳中和技术创新研究院牵头建设全省特种电池材料与技术重点实验室。 导读： 2025年上半年国内科学仪器行业有40起融资事件公开披露，与2024年同期几乎持平。本轮投融资热潮不仅集中在"国产替 代"与"关键技术突破"，更呈现出向"场景化应用落地"倾斜的新趋势。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 近日，浙江省科技厅公布2024年全省重点实验室认定结果名单，由在温高校、科研院所牵头建设的8家实验室榜上有 名。目前，温州市共拥有16家全省重点实验室，总数位居浙江省第三。 实验室是最具代表性的应用基础研究平台之一。2023年，浙江省启动全省重点实验室重组和系统化提升，聚焦重点领 域加强科技基础能力建设，提升基础研究和原始创新能力，建设一批高能级科创平台，支撑构建现代化产业体系。此次 认定的实 ...

导读： 近期，教育部重大慢病发病机制及综合诊疗医药基础研究创新中心设备更新项目的多个中标结果 出炉，总中标金额约1.03亿元。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我 们的推送。 近期，教育部重大慢病发病机制及综合诊疗医药基础研究创新中心（ 依托于中国医科大学， 设 备 更 新 项 目 的 多 个 中 标 结 果 出 炉 ， 总 中 标 金 额 超 亿 元 ， 中 标 产 品 包 括 凝 胶 成 像 系 统 、 流 变 仪、组织透明化系统、多功能酶标仪、微滴式数字PCR仪、光片显微镜、原子力显微镜、分选 型流式细胞仪等。 | 大通量玻片扫描仪 | 徕卡 | | HS50 | 1 | 818800 | | --- | --- | --- | --- | --- | --- | | 气质联用仪单四极杆 | Thermo | | ISQ 7610 | 1 | 945800 | | 平面微电极阵列记录系统 | Alpha | MED | MED64 | 1 | 985000 | | | Scientific | | | | | | 动物代谢监测分析系 ...

导读： 本文以国内50家上市仪器公司为研究对象，深入剖析研发与销售员工薪酬情况，为您揭开仪器行 业人才竞争的真实面纱。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我 们的推送。 6 月 14 日 上 午 ， 首 届 全 国 大 学 生 科 学 仪 器 创 新 大 赛 启 动 仪 式 在 北 京 航 空 航 天 大 学 校 友 之 家 举 办。本次大赛由中国仪器仪表学会、北京航空航天大学、北京市科学技术委员会、中关村科技 园区管理委员会、中关村科学城管理委员会和中关村发展集团共同主办，由北京中关村集成电 路设计园发展有限责任公司、北京航空航天大学集成电路科学与工程学院、北京新材料和新能 源科技发展中心承办，旨在挖掘大学生在科学仪器领域的创新能力，激发大学生科研与创业热 情，培育一批以大学生为主体的活力足、技术特点鲜明的青年人才队伍与初创企业。本次启动 仪式，来自政府、高校和科研院所的领导、专家和学者、合作伙伴等共100余人到场见证。 北航副校长赵巍胜指出，国产高端科学仪器的广泛使用是建设科技强国的基本特征，北航始终 坚持以服务国家战略需求为导向，致力 ...

Core Viewpoint - Shenzhen is accelerating the construction of a globally influential industrial technology innovation center, driven by significant R&D investments and a strategic focus on high-quality development [2][3]. Group 1: R&D Investment and Innovation - Shenzhen's R&D investment reached 223.66 billion yuan in 2024, with a growth rate of 18.9%, marking nine consecutive years of double-digit growth [2]. - The city's strategic emerging industries accounted for over 42.3% of the regional GDP in 2024, with advanced manufacturing as a core driver of high-quality development [3]. Group 2: Financial Support for Technology Enterprises - The Industrial and Commercial Bank of China (ICBC) Shenzhen Branch has restructured its technology financial services to support the growth of "hard technology" enterprises, focusing on long-term capital injection [3][4]. - By May 2025, the financing balance for technology enterprises at ICBC Shenzhen exceeded 160 billion yuan, with over 5,000 credit clients, reflecting a robust growth in its professional service system [4]. Group 3: Innovative Financing Mechanisms - ICBC Shenzhen has shifted its credit evaluation from traditional asset-based assessments to a focus on future value indicators, such as talent structure and R&D capabilities [6]. - The bank has developed a unique "three-in-one" evaluation mechanism that emphasizes the potential of technology enterprises rather than current financial metrics [6]. Group 4: Comprehensive Product Offerings - ICBC Shenzhen has created a diverse product matrix that supports technology enterprises throughout their lifecycle, including products for R&D investment and mergers and acquisitions [8]. - The bank has successfully implemented cross-border intellectual property pledge financing, facilitating the flow of technology resources between Hong Kong and mainland China [8]. Group 5: Ecosystem Development - ICBC Shenzhen is actively building a "technology innovation ecosystem" that connects government, capital markets, and industry resources, enhancing the integration of innovation, industry, and finance [9]. - The bank has organized over 20 investment roadshows, helping more than 120 small and medium-sized technology enterprises connect with national investment institutions [9]. Group 6: Digital Transformation - ICBC Shenzhen has developed a digital platform that enhances operational efficiency and supports technology enterprises in obtaining financing and tailored financial solutions [10]. - Since its launch, the digital platform has efficiently approved over 130 cutting-edge technology enterprises, showcasing the bank's commitment to leveraging technology in financial services [10].